Skip to main content

Table 3 Common surgery-related complications

From: Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma

Complicaions

ENPG alone group No./Total (%)

Consolidation immunotherapy group No./Total (%)

χ2

p-value

Nasal congestion

2 (10.0)

2 (20.0)

0.577

0.448

Dysphagia

5 (25.0)

1 (10.0.)

0.938

0.333

Nasopharyngeal hemorrhage

2 (10.0)

1 (10.0)

0

1.000

Nasopharyngeal necrosis

2 (10.0)

0 (0)

1.071

0.301

Facial numbness

1 (5.0)

1 (10.0)

0.268

0.605

Limitation of mouth opening

1 (5.0)

1 (10.0)

0.268

0.605

Cerebral infraction

1 (5.0)

0 (0)

0.517

0.472

  1. Abbreviation: ENPG endoscopic nasopharyngectomy